Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder.
about
The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based surveyInfectious MononucleosisFluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.Progress, prospects, and problems in Epstein-Barr virus vaccine development.Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature.Allogeneic transplantation in the UK: an aggregation of marginal gains?Peripheral Blood Epstein-Barr Viral Nucleic Acid Surveillance as a Marker for Posttransplant Cancer Risk.Epstein-Barr virus infection in adult renal transplant recipients.Epstein-Barr virus DNA monitoring in serum and whole blood in pediatric liver transplant recipients who do or do not discontinue immunosuppressive therapy.Epstein-Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6-month study.Monoclonal gammopathy of undetermined significance in pediatric kidney transplant: a possible role of Epstein-Barr virus.Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load.Comprehensive review of post-organ transplant hematologic cancers.Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.
P2860
Q21093165-C1614997-D8C1-45CF-B8C7-D135A75FE3E2Q26783692-27728595-DC18-43C6-B7ED-8116B69D08E1Q33634792-E043E901-82E0-49D4-A33B-EBFF24234780Q33812640-1080E914-8489-46C0-9C7B-805DF66FA662Q38087167-49894D4D-1B58-4791-AC3F-D0E2EADAAA2FQ38124363-C1CDB790-12D4-406C-9491-553018D35278Q38908687-57B95AF4-A2DF-4894-BCE1-C687C590483BQ39194877-0DD88FA8-6325-4575-BE46-961CE6DDF4A6Q40389653-D5581C39-5044-410A-BC92-8E621AB760BEQ40634214-E9530A55-6502-4EFA-A24B-A13029CF43C5Q42245693-BF415A9E-1DEA-43A7-AB4F-0A92C9E04302Q42263974-9BB7E579-CD82-4809-B17C-02EEF3FD6307Q43161944-BDD43EF9-D884-4F45-B0AE-1184FC2DEC85Q47572480-70B80922-EBC3-48E3-B945-4E8EE8514F90Q55312268-2423E671-376D-46BE-8B96-145BB7D06F58
P2860
Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantitative Epstein-Barr viru ...... lymphoproliferative disorder.
@en
Quantitative Epstein-Barr viru ...... lymphoproliferative disorder.
@nl
type
label
Quantitative Epstein-Barr viru ...... lymphoproliferative disorder.
@en
Quantitative Epstein-Barr viru ...... lymphoproliferative disorder.
@nl
prefLabel
Quantitative Epstein-Barr viru ...... lymphoproliferative disorder.
@en
Quantitative Epstein-Barr viru ...... lymphoproliferative disorder.
@nl
P2093
P2860
P1476
Quantitative Epstein-Barr viru ...... lymphoproliferative disorder.
@en
P2093
Amy B Karger
Beth D Mullan
Carol J Holman
Henry H Balfour
Richard C Brundage
P2860
P304
P356
10.1111/J.1399-0012.2012.01608.X
P577
2012-03-04T00:00:00Z